JP2016533332A5 - - Google Patents

Download PDF

Info

Publication number
JP2016533332A5
JP2016533332A5 JP2016516958A JP2016516958A JP2016533332A5 JP 2016533332 A5 JP2016533332 A5 JP 2016533332A5 JP 2016516958 A JP2016516958 A JP 2016516958A JP 2016516958 A JP2016516958 A JP 2016516958A JP 2016533332 A5 JP2016533332 A5 JP 2016533332A5
Authority
JP
Japan
Prior art keywords
protein
nanoparticle
self
amino acid
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2016516958A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016533332A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/057240 external-priority patent/WO2015048149A1/en
Publication of JP2016533332A publication Critical patent/JP2016533332A/ja
Publication of JP2016533332A5 publication Critical patent/JP2016533332A5/ja
Ceased legal-status Critical Current

Links

JP2016516958A 2013-09-24 2014-09-24 自己集合型ナノ粒子ワクチン Ceased JP2016533332A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361881848P 2013-09-24 2013-09-24
US61/881,848 2013-09-24
PCT/US2014/057240 WO2015048149A1 (en) 2013-09-24 2014-09-24 Self-assembled nanoparticle vaccines

Publications (2)

Publication Number Publication Date
JP2016533332A JP2016533332A (ja) 2016-10-27
JP2016533332A5 true JP2016533332A5 (show.php) 2017-11-02

Family

ID=51662365

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016516958A Ceased JP2016533332A (ja) 2013-09-24 2014-09-24 自己集合型ナノ粒子ワクチン

Country Status (5)

Country Link
US (1) US20150110825A1 (show.php)
EP (1) EP3049107A1 (show.php)
JP (1) JP2016533332A (show.php)
CA (1) CA2925201A1 (show.php)
WO (1) WO2015048149A1 (show.php)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9630994B2 (en) 2014-11-03 2017-04-25 University Of Washington Polypeptides for use in self-assembling protein nanostructures
SG11201706118XA (en) * 2015-01-29 2017-08-30 Agency Science Tech & Res Nanocapsules carrying chikungunya-associated peptides
US20190022210A1 (en) * 2015-11-06 2019-01-24 Victor G. Solodushko Novel platform dna vaccine
US20180312545A1 (en) * 2015-11-09 2018-11-01 Curevac Ag Optimized nucleic acid molecules
EP3474893A1 (en) 2016-06-27 2019-05-01 The U.S.A. as represented by the Secretary, Department of Health and Human Services Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigens
TWI634899B (zh) * 2016-11-22 2018-09-11 國立臺灣大學 包含類b肝病毒顆粒作為佐劑的疫苗組成物
TWI683826B (zh) * 2016-11-22 2020-02-01 國立臺灣大學 重組rsv抗原
SG11201908999QA (en) * 2017-04-04 2019-10-30 Univ Washington Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus f proteins and their use
JP7265547B6 (ja) 2017-08-04 2023-05-11 ザ ホスピタル フォー シック チルドレン 抗体およびワクチン送達用のナノ粒子プラットフォーム
SG11202005772YA (en) * 2018-01-06 2020-07-29 Emergex Vaccines Holding Ltd Mhc class i associated peptides for prevention and treatment of multiple flavi virus
AU2019228551B2 (en) 2018-02-28 2025-07-24 University Of Washington Self-assembling nanostructure vaccines
US20220017881A1 (en) * 2018-06-08 2022-01-20 Modalis Therapeutics Corporation MODIFIED Cas9 PROTEIN AND USE THEREOF
KR102076917B1 (ko) * 2018-10-25 2020-02-13 연세대학교 산학협력단 자가조립 나노 입자를 제조하기 위한 유전자 재조합 발현 벡터 시스템 및 이를 이용하는 방법
WO2021014385A1 (en) 2019-07-24 2021-01-28 Glaxosmithkline Biologicals Sa Modified human cytomegalovirus proteins
CN112439056B (zh) * 2019-08-28 2022-05-31 中国农业科学院生物技术研究所 基于自组装铁蛋白纳米抗原颗粒及由其制备的o型口蹄疫疫苗和应用
US20230234992A1 (en) 2020-06-05 2023-07-27 Glaxosmithkline Biologicals Sa Modified betacoronavirus spike proteins
WO2023144665A1 (en) 2022-01-28 2023-08-03 Glaxosmithkline Biologicals Sa Modified human cytomegalovirus proteins
CN117567652B (zh) * 2024-01-19 2024-05-14 北京安百胜生物科技有限公司 一种重组呼吸道合胞病毒颗粒抗原

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200613552A (en) * 2004-08-11 2006-05-01 Hoffmann La Roche Mutant interleukin-15 polypeptides
WO2009033004A1 (en) * 2007-09-07 2009-03-12 Montana State University Protein cages and their uses
EP2222710B8 (en) * 2007-12-24 2016-10-12 ID Biomedical Corporation of Quebec Recombinant rsv antigens
WO2010075491A2 (en) * 2008-12-24 2010-07-01 University Of Rochester Recombinant expression of self-folding neutralizing epitope-bearing subdomains of the respiratory syncytial virus attachment and fusion proteins
NO2707385T3 (show.php) * 2011-05-13 2018-02-17
US20130049342A1 (en) * 2011-08-25 2013-02-28 James Michael Cottrell Trailer chassis hold down system
CA2849822C (en) * 2011-09-23 2021-05-11 Gary J. Nabel, M.D. Novel influenza hemagglutinin protein-based vaccines
MX2014003777A (es) * 2011-09-30 2015-05-15 Novavax Inc Vacuna de nanoparticulas de proteinas f del rsv recombinantes para el virus respiratorio sincitial.
US10017543B2 (en) * 2013-03-13 2018-07-10 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Prefusion RSV F proteins and their use

Similar Documents

Publication Publication Date Title
JP2016533332A5 (show.php)
JP6957580B2 (ja) 新規多価ナノ粒子に基づくワクチン
JP2015509707A5 (show.php)
JP2015501840A5 (show.php)
JP2009523422A5 (show.php)
US20130236491A1 (en) Spherical nano and microparticles derived from plant viruses for the display of foreign proteins or epitopes
JP2015508284A5 (show.php)
JP2014500724A5 (show.php)
JP2012095652A5 (show.php)
JP7466271B2 (ja) アデノウイルスコートタンパク質由来送達賦形剤
JP2014507146A5 (show.php)
JP2019506175A5 (show.php)
JP2014502156A5 (show.php)
Mao et al. Surface display on lactic acid bacteria without genetic modification: strategies and applications
JP2015506705A5 (show.php)
JP2012515557A5 (show.php)
JP2016514713A5 (show.php)
JP2018524019A5 (show.php)
JP2010538619A5 (show.php)
JP2014519817A5 (show.php)
Lee et al. Nanoglue: an alternative way to display cell-internalizing peptide at the spikes of hepatitis B virus core nanoparticles for cell-targeting delivery
JP6964518B2 (ja) ヤツメウナギ由来の配列への融合による組換えタンパク質の多量体化
JP2019502404A5 (show.php)
CN107344969B (zh) 一种纳米流感疫苗及构建方法和应用
JP2018505135A5 (show.php)